Bill119th CongressFiled Jul 21, 2026
S. 5059
A bill to amend the Public Health Service Act to streamline the review of biosimilar biological products.
Bill journey · stage 2 of 5
Under committee review
FiledFiled
CommitteeComm.
PassedFloor
Both ChambersBoth
Became LawLaw
What it does
A plain-language summary from the Congressional Research Service isn’t available yet for this bill. CRS summaries are typically posted within a few weeks of introduction.
What just happenedJul 21, 2026
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Who’s behind it
Sen. Moody, Ashley [R-FL](R-FL)Sponsor
3 cosponsors